Trademark Search
Owners
American Board of Obstetrics and Gynecology, Inc.
BOARD CERTIFIED AMERICAN BOARD OF OBSTETRICS + GYNECOLOGY GYNECOLOGIC ONCOLOGY
no statement of use filed
on 26 Oct 2020
Last Applicant/ Owned by
2915 Vine Street
Dallas
TX
75204
Serial Number
88038160 filed on 15th Jul 2018
Registration Number
N/A
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
"BOARD CERTIFIED", "BOARD OF OBSTETRICS + GYNECOLOGY" AND "GYNECOLOGIC ONCOLOGY"
Medical services in the field of obstetrics and gynecology The mark consists of the terms "BOARD CERTIFIED" in bold type above the words "AMERICAN BOARD OF OBSTETRICS + GYNECOLOGY" above the words "GYNECOLOGIC ONCOLOGY" with a line above and below the words "GYNECOLOGIC ONCOLOGY" and a wide rectangle to the left side of the entire mark. BOARD CERTIFIED AMERICAN BOARD OF OBSTETRICS AND GYNECOLOGYRead More
Medical services in the field of obstetrics and gynecology
No 88038160
No Service/Collective Mark
No
No
No
No
No
No
No
No
No
26.11.21 -
Rectangles that are completely or partially shaded
26.17.13 -
Letters or words underlined and/or overlined by one or more strokes or lines
The mark consists of the terms "BOARD CERTIFIED" in bold type above the words "AMERICAN BOARD OF OBSTETRICS + GYNECOLOGY" above the words "GYNECOLOGIC ONCOLOGY" with a line above and below the words "GYNECOLOGIC ONCOLOGY" and a wide rectangle to the left side of the entire mark.
| Status Date | Action Taken |
|---|---|
| 26th Oct 2020 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| 26th Oct 2020 | ABANDONMENT - NO USE STATEMENT FILED |
| 21st Aug 2020 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 20th Aug 2020 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 20th Aug 2020 | EXTENSION 1 GRANTED |
| 08th Jul 2020 | PETITION TO REVIVE-GRANTED |
| 08th Jul 2020 | TEAS PETITION TO REVIVE RECEIVED |
| 08th Jul 2020 | NOTICE OF REVIVAL - E-MAILED |
| 08th Jul 2020 | EXTENSION RECEIVED WITH TEAS PETITION |
| 08th Jun 2020 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
